Prevalence of Hepatitis (A–E) and HTLV‐I/II Infection Markers in Hemodialysis Patients of Central Greece
Identifieur interne : 001400 ( Istex/Curation ); précédent : 001399; suivant : 001401Prevalence of Hepatitis (A–E) and HTLV‐I/II Infection Markers in Hemodialysis Patients of Central Greece
Auteurs : I. Stefanidis ; E. K. Zervou [Grèce] ; C. Rizos ; C. Liaskos ; S. Zarogiannis ; V. Liakopoulos ; G. Kyriakopoulos ; G. N. DalekosSource :
- Hemodialysis International [ 1492-7535 ] ; 2004-01.
Abstract
Objective: The aim of this study was to assess the prevalence of serological and molecular markers of hepatitis (A–E) and human T‐lymphotropic viruses (HTLV) in hemodialysis (HD) patients of central Greece. Methods: 370 patients (246 males, 60 ± 14 years) attending the renal units (RUs) of central Greece (n = 5) were tested for anti‐HAV IgG, hepatitis B virus markers, anti‐HCV, anti‐HEV, and anti‐HTLV‐I/II with ELISA. In 131 casual samples, regardless of anti‐HCV status, a sensitive, qualitative HCV‐RNA assay (Versant®, Bayer) based on transcription‐mediated amplification (TMA) was applied. Results: Previous HBV infection (anti‐HBc) was found in 48% and current HBV infection in 5.5% (HbsAg) of the patients. Anti‐HAV was detected in 94% while anti‐HDV and anti‐HTLV were negative. Anti‐HCV prevalence was 23% varying from 11 to 36% in the different RUs. Frequency of anti‐HEV (4.1%) was also highly varying (1.4–9.8%). There was no association between the infection markers and age, sex, or history of transfusion. Anti‐HCV correlated with duration of HD. HCV‐RNA was detected in 44/131 samples. In 15 cases results of anti‐HCV and TMA were contradicting. Two anti‐HCV negative samples were HCV‐RNA positive (2.3%). Conclusion: In RUs of central Greece, a high prevalence of HCV infection was found, associated with the duration of HD. The high prevalence of anti‐HEV found in 1 RU must be investigated further. In some of anti‐HCV‐negative patients viremia was detected. This result indicates that a considerable number of HCV infections are serologically occult. HCV‐RNA testing, regardless of the anti‐HCV status, has to be considered seriously in HD patients.
Url:
DOI: 10.1111/j.1492-7535.2004.0085bh.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001400
Links to Exploration step
ISTEX:0A553DA490BEC43415E2F4F409C0D26E5132D7CECuration
No country items
I. Stefanidis<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of Hepatitis (A–E) and HTLV‐I/II Infection Markers in Hemodialysis Patients of Central Greece</title>
<author><name sortKey="Stefanidis, I" sort="Stefanidis, I" uniqKey="Stefanidis I" first="I." last="Stefanidis">I. Stefanidis</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Zervou, E K" sort="Zervou, E K" uniqKey="Zervou E" first="E. K." last="Zervou">E. K. Zervou</name>
<affiliation wicri:level="1"><mods:affiliation>Blood Bank at the University Hospital of Ioannina, Greece.</mods:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Blood Bank at the University Hospital of Ioannina</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rizos, C" sort="Rizos, C" uniqKey="Rizos C" first="C." last="Rizos">C. Rizos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liaskos, C" sort="Liaskos, C" uniqKey="Liaskos C" first="C." last="Liaskos">C. Liaskos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Zarogiannis, S" sort="Zarogiannis, S" uniqKey="Zarogiannis S" first="S." last="Zarogiannis">S. Zarogiannis</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liakopoulos, V" sort="Liakopoulos, V" uniqKey="Liakopoulos V" first="V." last="Liakopoulos">V. Liakopoulos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kyriakopoulos, G" sort="Kyriakopoulos, G" uniqKey="Kyriakopoulos G" first="G." last="Kyriakopoulos">G. Kyriakopoulos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Dalekos, G N" sort="Dalekos, G N" uniqKey="Dalekos G" first="G. N." last="Dalekos">G. N. Dalekos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0A553DA490BEC43415E2F4F409C0D26E5132D7CE</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1492-7535.2004.0085bh.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-89KLVWPQ-G/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001400</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001400</idno>
<idno type="wicri:Area/Istex/Curation">001400</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Prevalence of Hepatitis (A–E) and HTLV‐I/II Infection Markers in Hemodialysis Patients of Central Greece</title>
<author><name sortKey="Stefanidis, I" sort="Stefanidis, I" uniqKey="Stefanidis I" first="I." last="Stefanidis">I. Stefanidis</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Zervou, E K" sort="Zervou, E K" uniqKey="Zervou E" first="E. K." last="Zervou">E. K. Zervou</name>
<affiliation wicri:level="1"><mods:affiliation>Blood Bank at the University Hospital of Ioannina, Greece.</mods:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Blood Bank at the University Hospital of Ioannina</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rizos, C" sort="Rizos, C" uniqKey="Rizos C" first="C." last="Rizos">C. Rizos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liaskos, C" sort="Liaskos, C" uniqKey="Liaskos C" first="C." last="Liaskos">C. Liaskos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Zarogiannis, S" sort="Zarogiannis, S" uniqKey="Zarogiannis S" first="S." last="Zarogiannis">S. Zarogiannis</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liakopoulos, V" sort="Liakopoulos, V" uniqKey="Liakopoulos V" first="V." last="Liakopoulos">V. Liakopoulos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kyriakopoulos, G" sort="Kyriakopoulos, G" uniqKey="Kyriakopoulos G" first="G." last="Kyriakopoulos">G. Kyriakopoulos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Dalekos, G N" sort="Dalekos, G N" uniqKey="Dalekos G" first="G. N." last="Dalekos">G. N. Dalekos</name>
<affiliation><mods:affiliation>Division of Nephrology and Department of Internal Medicine, School of Medicine, University Thessaly, Larissa</mods:affiliation>
<wicri:noCountry code="subField">Larissa</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Hemodialysis International</title>
<title level="j" type="alt">HEMODIALYSIS INTERNATIONAL</title>
<idno type="ISSN">1492-7535</idno>
<idno type="eISSN">1542-4758</idno>
<imprint><biblScope unit="vol">8</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="101">101</biblScope>
<biblScope unit="page" to="101">101</biblScope>
<biblScope unit="page-count">100</biblScope>
<publisher>Blackwell Science Inc</publisher>
<pubPlace>Oxford, UK; Malden, USA</pubPlace>
<date type="published" when="2004-01">2004-01</date>
</imprint>
<idno type="ISSN">1492-7535</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1492-7535</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective: The aim of this study was to assess the prevalence of serological and molecular markers of hepatitis (A–E) and human T‐lymphotropic viruses (HTLV) in hemodialysis (HD) patients of central Greece. Methods: 370 patients (246 males, 60 ± 14 years) attending the renal units (RUs) of central Greece (n = 5) were tested for anti‐HAV IgG, hepatitis B virus markers, anti‐HCV, anti‐HEV, and anti‐HTLV‐I/II with ELISA. In 131 casual samples, regardless of anti‐HCV status, a sensitive, qualitative HCV‐RNA assay (Versant®, Bayer) based on transcription‐mediated amplification (TMA) was applied. Results: Previous HBV infection (anti‐HBc) was found in 48% and current HBV infection in 5.5% (HbsAg) of the patients. Anti‐HAV was detected in 94% while anti‐HDV and anti‐HTLV were negative. Anti‐HCV prevalence was 23% varying from 11 to 36% in the different RUs. Frequency of anti‐HEV (4.1%) was also highly varying (1.4–9.8%). There was no association between the infection markers and age, sex, or history of transfusion. Anti‐HCV correlated with duration of HD. HCV‐RNA was detected in 44/131 samples. In 15 cases results of anti‐HCV and TMA were contradicting. Two anti‐HCV negative samples were HCV‐RNA positive (2.3%). Conclusion: In RUs of central Greece, a high prevalence of HCV infection was found, associated with the duration of HD. The high prevalence of anti‐HEV found in 1 RU must be investigated further. In some of anti‐HCV‐negative patients viremia was detected. This result indicates that a considerable number of HCV infections are serologically occult. HCV‐RNA testing, regardless of the anti‐HCV status, has to be considered seriously in HD patients.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001400 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001400 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:0A553DA490BEC43415E2F4F409C0D26E5132D7CE |texte= Prevalence of Hepatitis (A–E) and HTLV‐I/II Infection Markers in Hemodialysis Patients of Central Greece }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |